(Fmoc-Cys-OH)2 CAS No.135273-01-7 / Cat No.EBD2224502
N,N'-bis(Fmoc)-L-cystine
(fmoc-cys)2
n-alpha,n-alpha-bis-fmoc-l-cystine
n,n'-di-9-fluorenylmethoxycarbonyl-l-cystine
(fmoc-cys-oh)2 (disulfide bond)
(2r,2'r)-3,3'-disulfanediylbis(2-((((9h-fluoren-9-yl)methoxy)carbonyl)amino)propanoic acid)
n,n'-bis-fmoc-l-cystine
nα,nα-bis-fmoc-l-cystine
NMR Spectrum
1H NMR
13C NMR
-
Cas No.: 135273-01-7
-
Cas No.: 654664-63-8
-
Cas No.: 371770-32-0
-
![Cyclopentanecarboxamide, 1-[(1-oxopentyl)amino]-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-,CAS No. 748812-53-5.](https://public.whmall.com/system/0/chemical/image/2007/09/04/1188888888-2331359_C25H30N6O2.png "Cyclopentanecarboxamide, 1-[(1-oxopentyl)amino]-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-,CAS No. 748812-53-5.")
Cas No.: 748812-53-5
-
![(S)-N-Butyryl-N-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]valine,CAS No. 952652-79-8.](https://public.whmall.com/system/0/chemical/image/2007/09/04/1188888888-2335294_C23H27N5O3.png "(S)-N-Butyryl-N-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]valine,CAS No. 952652-79-8.")
Cas No.: 952652-79-8
-
Cas No.: 207611-87-8
-
Cas No.: 302554-81-0
-
Cas No.: 107447-04-1
-
![(3S)-methyl 1-isobutyl-7-methoxy-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate,CAS No. 107447-06-3.](https://public.whmall.com/system/0/chemical/image/2007/09/04/1188888888-2304933_C18H24N2O3.png "(3S)-methyl 1-isobutyl-7-methoxy-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate,CAS No. 107447-06-3.")
Cas No.: 107447-06-3
-
Cas No.: 136778-40-0
-
Cas No.: 142115-17-1
-
Cas No.: 110761-76-7
-
Cas No.: 270568-72-4
-
Cas No.: 157823-76-2
-
Cas No.: 123702-97-6
-
Cas No.: 439088-73-0
-
Cas No.: 327156-92-3
-
Cas No.: 371111-67-0
-
![2-Azabicyclo[3.1.0]hexane-3-carboxamide, (1S,3S,5S)-,CAS No. 361440-68-8.](https://public.whmall.com/system/0/chemical/image/2007/09/04/1188888888-2298267_C6H10N2O.png "2-Azabicyclo[3.1.0]hexane-3-carboxamide, (1S,3S,5S)-,CAS No. 361440-68-8.")
Cas No.: 361440-68-8
-
Cas No.: 121147-94-2
-
Cas No.: 457654-76-1
